What is the drug of choice for VRE infection?
•
4 min read
The emergence of Vancomycin-resistant enterococci (VRE) is a major concern in healthcare settings, significantly limiting antibiotic treatment options. While treatment strategies for VRE infection depend on the site and severity, the selection process is complex due to limited therapeutic choices and potential resistance development. The determination of the optimal drug involves a careful consideration of several factors, including the specific type of infection and individual patient characteristics.
